ABSTRACT
Introduction:COVID-19 disease caused by SARS-COV-2 belongs to the family coronaviridae.In worldwide, it affected more than 100 million people and 2.2 million patient died. Many studies have been conducted to determine the clinical, biological, and radiological characteristics of COVID-19 for better identification of infected people at an early stage and stop disease development to an advanced state. Aim(s): The aim of our this study was to take advantage of the biochemical and haematological parameters in predicting the prognosis and mortality in disease severity COVID-19 patients. Material(s) and Method(s): This study included total of 100 COVID-19 positive patients were included. Biochemistry and hematological parameters were tested for the COVID-19 positive patients and patients were categorized as mild, moderate, and severely ill based on clinical status. Result(s): The Biochemical parameters and inflammatory markers like D-Dimer, C-reactive protein (CRP), Ferritin, and Lactate Dehydrogenase (LDH) levels differed significantly between mild, moderate and severely ill cases respectively. The mean difference of hematological parameters like total leucocyte count, neutrophil %, monocyte and lymphocyte % were shows significant different between mild, moderate and severe symptoms cases. Conclusion(s): The biochemical parameters, inflammatory markers haematological indices are a good guide for predicting the severity and disease outcome of corona virus disease and could be used as a screening tool to identify patients requiring intensive care.